QuadMedicine KRX:464490KOSDAQ
쿼드메디슨 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days6
DART filings, 7 days2
Articles tracked9since Sep 11
In Q2 2026, QuadMedicine reported an operating loss of ₩2.4bn. QuadMedicine (쿼드메디슨) appeared in 6 Korean news articles and 2 DART filings over the past seven days. Coverage peaked on Oct 28 with 6 articles.
Filing signals Insider buying Clinical trial filing Swung to loss Screener
QuadMedicine quarterly results consolidated, KRW
| Quarter | Operating profit | Net income |
|---|---|---|
| Q2 2026 | −₩2.4bn | −₩2.3bn |
| Q1 2026 | −₩4.4bn | −₩4.6bn |
| Q2 2025 | ₩34m | −₩370m |
| Q1 2025 | −₩3.4bn | −₩3.4bn |
| Q4 2024 derived | ₩971m | ₩942m |
| Q3 2024 | −₩895m | −₩1.3bn |
| Q2 2024 | −₩1.4bn | −₩1.4bn |
| Q1 2024 | −₩3.2bn | −₩3.2bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
QuadMedicine top stories 2 weeks, by number of outlets
- 1
- 2
- 3
Latest QuadMedicine news Korean headlines
-
쿼드메디슨, 美 AAPS서 탈모 분야 마이크로니들 연구 성과 공개
2 more on this story · 2 outlets
- 쿼드메디슨, 美서 탈모 분야 신규 마이크로니들 플랫폼 연구 성과 공개한국경제 · Oct 28 10:15
- 쿼드메디슨, AAPS서 탈모 분야 마이크로니들 플랫폼 연구 성과 공개라포르시안 · Oct 28 15:18
-
쿼드메디슨, 탈모 치료제 전달 기술 다변화…美 AAPS서 'R-MAP' 연구 공개
1 more on this story · 1 outlets
- 쿼드메디슨, 탈모 치료제 전달 기술 다변화…美 AAPS서 'R-MAP' 연구 공개메디컬투데이 · Oct 28 09:08